Michael R. Shurin MD, PhD

Dr. Michael R Shurin joined the Faculty of the Department of Pathology at the University of Pittsburgh Medical Center in 1991 where he is a Professor of Pathology and Immunology and an Associate Director of the Division of Clinical Immunopathology. His main research interests are in the field of the tumor microenvironment, cancer-mediated immunomodulation, and dendritic cell vaccines for cancer immunotherapy.

At present, his research program focuses on the immune-modulating properties of chemotherapy and modulation of the tumor microenvironmental elements, including dendritic cells, regulatory T cells, myeloid-derived suppressor cells, and endothelial cells, as well as intratumoral cytokine network. Using a combination of immunological, molecular, and gene therapeutic methodologies, He is an author of more than a hundred peer-reviewed publications and numerous reviews, and editor of several books, including “Dendritic Cell in Cancer” and “The tumor immune environment” books, an organizer of several popular international conferences on Immune-Mediated Diseases, Immunodiagnostics and Immunomonitoring and Cancer Immunotherapy. He is a Member of several grant review and editorial boards and many clinical and research societies.